Space & Satellites
Varda and United Therapeutics Partner for Orbital Drug Manufacturing
Varda Space Industries and United Therapeutics collaborate to develop microgravity-enabled treatments for rare pulmonary diseases using orbital pharmaceutical manufacturing.
On May 13, 2026, Varda Space Industries and United Therapeutics Corporation announced a landmark collaboration to manufacture pharmaceuticals in low Earth orbit (LEO). The partnership focuses on developing microgravity-enabled treatments for rare pulmonary diseases, marking a significant milestone in the intersection of commercial spaceflight and biotechnology.
According to the official press release, this initiative represents the first-ever commercial research collaboration focused on space-based drug formulation aimed at producing tangible therapies for patients on Earth. By utilizing Varda’s automated reentry capsules, the companies aim to process small-molecule medicines in space and return them to Earth for clinical evaluation and eventual patient use.
This collaboration signals a major shift from traditional, government-funded research conducted on the International Space Station (ISS) to a dedicated commercial supply chain model. By leveraging the unique physics of zero gravity, the partnership strives to revolutionize how life-saving therapies are formulated and delivered.
The core advantage of orbital pharmaceutical manufacturing lies in the absence of Earth’s gravitational pull. On Earth, gravity induces sedimentation and convection currents that can disrupt how molecules assemble during the manufacturing process. In the weightless environment of space, these disruptive forces vanish.
According to the provided research report, this microgravity environment allows molecules to assemble more slowly and uniformly. The result is the creation of highly ordered crystal structures, known as polymorphs, that are either significantly purer or entirely impossible to synthesize in a terrestrial laboratory.
By exploiting microgravity’s influence on molecular structure and crystallization, Varda and United Therapeutics hope to achieve several critical breakthroughs in drug formulation. The targeted benefits of this orbital processing include:
Varda Space Industries, an El Segundo, California-based startup founded in 2021 and backed by Founders Fund, is pioneering the infrastructure required for this endeavor. Unlike traditional microgravity research on the ISS, which is frequently bottlenecked by crew schedules, contamination risks, and long wait times for return flights, Varda utilizes automated, free-flying “W-series” reentry capsules.
These capsules are designed to launch as secondary payloads, often aboard SpaceX missions. Once in orbit, they autonomously process materials before returning the finished products to Earth, landing at designated recovery sites such as the Australian desert. Leadership from both companies emphasized the transformative potential of moving pharmaceutical development into orbit. In the official announcement, Varda Space Industries CEO Will Bruey highlighted the unique advantages of their platform:
“Microgravity gives us a fundamentally different environment to manufacture pharmaceuticals that are otherwise impossible on Earth. Our collaboration with United Therapeutics strives to pioneer a new era in clinical development by completing the bridge from microgravity science to patient benefit on Earth.”
Martine Rothblatt, Ph.D., Chairperson and CEO of United Therapeutics, noted in the release that the collaboration will allow the biotechnology firm to explore how space-based manufacturing could contribute to significant improvements for rare pulmonary disease treatments.
Michael Reilly, Chief Strategy Officer of Varda Space Industries, underscored the commercial novelty of the venture, pointing out the historical limitations of space research:
“We’ve been learning from space for years, but I can’t name anything manufactured in space, brought down to Earth, and sold. So that is a first, or it will be a first.”
United Therapeutics Corporation (Nasdaq: UTHR) is a biotechnology giant with a market capitalization of $24.69 billion, specializing in innovative therapies for life-threatening conditions like pulmonary arterial hypertension. Following the announcement of the collaboration, industry reports noted that United Therapeutics’ stock was trading near its 52-week high of $609.35, reflecting strong investor confidence in the company’s innovative pipeline.
While the specific compounds and exact financial terms of the deal remain undisclosed, the agreement stipulates that United Therapeutics is compensating Varda to help identify new crystal forms of its existing drugs.
The timeline for this orbital manufacturing initiative is advancing rapidly. According to the research report, a launch carrying United Therapeutics’ drug samples aboard a Varda capsule could occur as early as early 2027. Once the capsules return to Earth, scientists at United Therapeutics will rigorously test the newly formed polymorphs to evaluate their enhanced properties.
We observe that this partnership answers a long-standing question in the aerospace sector: whether orbital drug manufacturing can successfully transition from a scientific curiosity to a viable, scalable business model. For over two decades, microgravity research has been largely confined to the ISS, yielding promising scientific results that rarely translated into commercial manufacturing pipelines due to logistical and financial constraints.
As launch costs continue to decrease and automated satellite technology matures, space-based manufacturing is rapidly emerging as a practical tool for terrestrial industries. If Varda and United Therapeutics are successful in returning commercially viable, enhanced pharmaceuticals from orbit, it could pave the way for a new era of space-enabled medicine, fundamentally altering the economic landscape of both the commercial space sector and the global biotechnology industry. What is the goal of the Varda and United Therapeutics collaboration? How does microgravity improve drug manufacturing? When will the first manufacturing mission launch? How do the drugs return to Earth?
The Science of Microgravity Manufacturing
Targeted Pharmaceutical Benefits
Commercializing Orbital Infrastructure
Industry Perspectives
Financial Context and Next Steps
AirPro News analysis
Frequently Asked Questions (FAQ)
The partnership aims to develop improved formulations of treatments for rare pulmonary diseases by manufacturing small-molecule medicines in the microgravity environment of low Earth orbit.
In space, the absence of gravity eliminates sedimentation and convection currents. This allows molecules to assemble more slowly and uniformly, creating highly ordered crystal structures (polymorphs) that can improve a drug’s bioavailability, stability, and delivery methods.
A launch carrying United Therapeutics’ drug samples aboard a Varda reentry capsule is projected to happen as early as early 2027.
Varda utilizes automated “W-series” reentry capsules that process the materials in orbit and then reenter the Earth’s atmosphere, landing at designated recovery sites such as the Australian desert.
Sources
Photo Credit: Varda Space Industries
Space & Satellites
NASA SkyFall Mission to Deploy 3 Helicopters on Mars in 2028
NASA’s SkyFall mission will send three radar-equipped helicopters to Mars in 2028 to map subsurface water ice for future crewed missions.
The National Aeronautics and Space Administration (NASA) will deploy a fleet of three next-generation helicopters to Mars in late 2028 to map shallow subsurface water ice, a critical resource for future human exploration. The rotorcraft will utilize ground-penetrating radar to scout potential landing sites, addressing a major logistical hurdle for crewed missions.
Announced by NASA’s Jet Propulsion Laboratory (JPL), the SkyFall mission will target the Martian mid-northern latitudes. The mission represents a shift in planetary exploration architecture, as the helicopters will launch aboard the Space Reactor-1 Freedom (SR-1 Freedom) spacecraft, which utilizes a nuclear electric propulsion system, and will deploy without a traditional rover intermediary.
Operating aircraft in the Martian atmosphere, which has 1 percent of the density of Earth’s atmosphere, presents severe aerodynamic challenges. To carry heavier science payloads than their predecessor, the SkyFall helicopters require significantly faster rotor speeds to generate sufficient lift. On May 7, 2026, JPL engineers successfully accelerated the tips of the next-generation rotor blades beyond Mach 1 during 137 test runs in a specialized Mars simulation chamber.
Al Chen, Mars Exploration Program Manager at JPL, highlighted the difficulty of the engineering requirements.
“NASA had a great run with the Ingenuity Mars Helicopter, but we are asking these next-generation aircraft to do even more at the Red Planet. That’s not an easy ask. While everything about Mars is hard, flying there is just about the hardest thing you can do. That’s because its atmosphere is so incredibly thin that it is hard to generate lift, and yet Mars has significant gravity.” The primary instrument for the SkyFall fleet is a ground-penetrating radar designed to operate across a frequency range of 500 to 2,500 megahertz. On August 6, 2026, JPL confirmed the successful testing of a flexible, metallized fabric antenna made from polyester and Vectran. The material allows the antenna to bend during landings and snap back into position for flight. Christine Gebara, SkyFall Ground-Penetrating Radar Mechanical Lead at JPL, noted the scale of the instrument, stating that the antenna is about one and a half times longer than the helicopter’s legs.
The primary scientific objective of the SkyFall mission is to locate accessible, shallow water ice. Transporting sufficient water and rocket propellant from Earth for sustained human exploration is cost-prohibitive, making local resource utilization mandatory. Orbiting spacecraft cannot effectively map the top several yards of Martian regolith, necessitating low-altitude aerial surveys.
Adrian Tang, SkyFall Ground-Penetrating Radar Lead Instrument Scientist at JPL, explained the operational concept. “The only way to detect shallow subsurface ice remotely is to fly close to the ground. By flying low and slow, a SkyFall helicopter could capture radar images that resolve the fine layering where dry soil gives way to ice, detecting its presence and mapping its extent.”
Each SkyFall helicopter is expected to cover 0.6 to 1.2 miles (1 to 2 kilometers) during a standard 2.5-minute flight. NASA is currently evaluating candidate landing sites in the mid-northern latitudes between 30 and 45 degrees North. The agency will hold a virtual Landing Site Workshop on February 9 and 10, 2027, to gather input from the science community and prioritize these zones.
The SkyFall mission represents a direct evolution from the Ingenuity Mars Helicopter, a 3.97-pound (1.8-kilogram) technology demonstrator that performed the first powered, controlled flight on another planet on April 19, 2021. Ingenuity ultimately completed 72 flights over nearly three years. While Ingenuity carried no science instruments and relied on the Perseverance rover for communications, the SkyFall rotorcraft are larger and equipped with radar, cameras, and sensors. AeroVironment, an aerospace manufacturer headquartered in Arlington, Virginia, with manufacturing facilities in Simi Valley, California, is co-designing and co-manufacturing the SkyFall helicopters in partnership with JPL. This continues the collaboration that produced the Ingenuity rotorcraft.
The deployment sequence for SkyFall introduces new operational concepts. The helicopters will utilize a mid-air deployment system, releasing directly from an entry capsule to fly themselves to the Martian surface without a lander or rover intermediary. Following a planned initial Mars flyby in 2029, the fleet is scheduled to land in Fall 2030 and will communicate directly with orbiting spacecraft.
The SkyFall mission marks a critical transition in planetary aviation from experimental demonstration to operational necessity. By removing the rover as a communications relay and deployment platform, NASA is treating rotorcraft as independent, primary exploration vehicles. The integration of the Space Reactor-1 Freedom nuclear electric propulsion system for the transit phase indicates a broader shift in deep-space logistics, prioritizing the high-mass, high-power transit architectures required for future crewed missions. We view the success of the mid-air deployment sequence as the highest-risk phase of the mission, as it requires autonomous flight initiation immediately following atmospheric entry.
Engineering the next-generation rotorcraft
Mapping resources for human exploration
From technology demonstrator to operational fleet
AirPro News analysis
Photo Credit: NASA
Space & Satellites
SpaceX Crew-12 Splashes Down After 237-Day ISS Mission
Crew Dragon Freedom returns four astronauts to Earth on Oct. 8, 2026, completing SpaceX’s 12th NASA crew rotation flight.
The SpaceX Crew Dragon spacecraft Freedom splashed down in the Pacific Ocean off the coast of Los Angeles on October 8, 2026, safely returning four astronauts from a 237-day science expedition aboard the International Space Station (ISS).
The successful return marks the completion of the Crew-12 mission, the 12th operational crew rotation flight conducted by SpaceX under the National Aeronautics and Space Administration (NASA) Commercial Crew Program. According to a NASA press release, the capsule touched down at 11:34 a.m. EDT (15:34 UTC) following a nearly eight-month deployment in low Earth orbit.
Return operations for the Crew-12 astronauts began on October 7, 2026, when the hatch between the SpaceX Dragon spacecraft and the ISS was closed at 9:20 a.m. EDT. The crew had been officially relieved by a newly arrived rotation earlier in the month, though their departure experienced a slight delay due to unfavorable weather conditions in the designated splashdown zones.
Following undocking, the spacecraft executed its deorbit burn at approximately 10:46 a.m. EDT on October 8. NASA mission updates indicate that the capsule deployed its drogue parachutes at an altitude of 18,000 feet while traveling at a speed of approximately 350 mph. The main parachutes subsequently deployed, slowing the spacecraft for a controlled water landing at 11:34 a.m. EDT.
Immediately following the splashdown, recovery teams approached the capsule. The recovery ship hoisted the Dragon spacecraft onto the main deck to allow the crew to exit. The astronauts will undergo standard post-flight medical evaluations before beginning their journey back to NASA’s Johnson Space Center in Houston.
The Crew-12 complement included NASA astronauts Jessica Meir, serving as Commander, and Jack Hathaway, serving as Pilot. They were joined by Mission Specialists Sophie Adenot of the European Space Agency (ESA) and Andrey Fedyaev of Roscosmos.
During their 237 days aboard the orbital laboratory, the four-person crew conducted critical scientific research and completed four spacewalks. The mission duration adds significantly to the spaceflight experience of the crew members. For Commander Jessica Meir, the completion of the Crew-12 flight brings her total cumulative time in space to 440 days, placing her among the top 10 NASA astronauts for total days spent in orbit.
The Crew-12 mission represents SpaceX’s 13th crewed flight overall as part of the NASA Commercial Crew Program, a partnership designed to provide reliable crew transportation to and from the ISS. SpaceX remains the primary operational provider of crewed flights for the agency, facilitating continuous human presence and research in low Earth orbit.
The mission began on February 13, 2026, lifting off at 5:15 a.m. EST from Space Launch Complex 40 at Cape Canaveral Space Force Station in Florida atop a SpaceX Falcon 9 rocket. The launch followed initial weather delays that shifted the target date from February 11. The Crew Dragon Freedom then docked autonomously to the space-facing port of the ISS Harmony module at approximately 3:15 p.m. EST on February 14, 2026, where it remained for the duration of the expedition.
Re-entry and recovery operations
Crew-12 mission milestones
Commercial Crew Program context
Photo Credit: NASA
Space & Satellites
Blue Origin Invests $554.8M in Texas Manufacturing Campus
Blue Origin commits $554.8M to build Constellation Park in Hutto, TX, producing satellite and ground communications hardware.
Blue Origin will construct a 1.3-million-square-foot manufacturing campus in Hutto, Texas, backed by a $554.8 million capital investment to produce hardware for its emerging satellite and ground communications networks.
Announced in a press release on October 8, 2026, the facility will be named Constellation Park. The project represents a major expansion of the aerospace manufacturer’s footprint beyond launch vehicles and is expected to create more than 2,000 jobs over the next decade.
Constellation Park will serve as the central production hub for two of Blue Origin’s major communications programs. The primary focus is TeraWave, a satellite communications network designed to deliver up to 6 terabits per second of symmetrical data anywhere on Earth. The company is targeting enterprise, data center, and government users requiring resilient global connectivity.
The campus will also manufacture components for Quartz, a global ground communications network. The Quartz system features 3.7-meter aperture antennas that enable S-band and X-band connectivity for low Earth orbit missions. Alongside these primary networks, the Hutto facility will house manufacturing lines for key subsystems, including solar arrays, avionics, and telecommunications hardware.
The Office of the Texas Governor confirmed the financial scope of the project on October 8, 2026. Blue Origin Manufacturing LLC committed $554,780,000 in capital investment to develop the Williamson County site.
To support the expansion, the State of Texas extended an $18,171,000 Texas Enterprise Fund (TEF) grant to the company, along with a $10,000 Veteran Created Job Bonus. State officials noted that the project will drive growth among local suppliers in Central Texas.
Texas is the launchpad to a future of possibilities. Blue Origin’s sizeable expansion of their investment in Texas in support of their satellite communications network is testament to the state’s leadership in the advanced manufacturing and space industries. Governor Greg Abbott added that the state offers technology leaders the space, speed, and talent needed to rapidly scale operations.
Blue Origin established its initial presence in the state in 2006 with the opening of Launch Site One. Prior to the Constellation Park announcement, the company employed 550 people in Texas. The new facility is projected to add over 2,000 manufacturing and related jobs over the next 10 years.
Blue Origin Chief Executive Officer Dave Limp stated that the company is proud to grow its footprint in the state and tap into the local talent pool. Texas has long understood what it takes to lead in space exploration. We’re proud to grow our footprint here in Texas, tap into the world-class talent this state has to offer, and help ensure America remains the leader in space innovation. The half-billion-dollar investment in Constellation Park highlights a strategic maturation for Blue Origin. By committing heavy capital to the TeraWave and Quartz programs, the company is moving aggressively into the satellite and ground communications infrastructure market. This diversifies its portfolio beyond the core business of reusable launch vehicles and rocket engines. Establishing a dedicated, 1.3-million-square-foot production hub indicates that Blue Origin intends to vertically integrate its satellite manufacturing process, positioning itself to compete for high-bandwidth enterprise and government connectivity contracts.
Expanding into satellite and ground communications
State and local financial backing
Blue Origin’s growing Texas footprint
AirPro News analysis
Photo Credit: Blue Origin
-
Business Aviation6 days agoACJ Study: Family Offices Drive Business Aviation Demand
-
Space & Satellites6 days agoNASA SpaceX Crew-12 Return Targets October 7 Undocking
-
Space & Satellites7 days agoNASA Names SpaceX Crew-14 Astronauts for Spring 2027 ISS Mission
-
Aircraft Orders & Deliveries7 days agoACG Delivers Sixth Boeing 737-8 to Royal Air Maroc
-
Commercial Aviation6 days agoMenzies Aviation Expands to Full-Suite Services at KUL